Bluefin Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,000
Closed -$22.5K 310
2023
Q4
$22.5K Buy
+36,000
New +$7M ﹤0.01% 164

Other funds holding KRTX